trending Market Intelligence /marketintelligence/en/news-insights/trending/S_sLNryjNHCqUobk1hlfbg2 content esgSubNav
In This List

Medtronic's neurosurgery guidance system receives US FDA clearance

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation

Blog

Using Credit Analytics to Avoid Mispricing Insurance Premiums

Blog

Post-Webinar Q&A: Integrating Climate Risks into Credit Risk Portfolios


Medtronic's neurosurgery guidance system receives US FDA clearance

The U.S. Food and Drug Administration has cleared Medtronic PLC's Stealth Autoguide system, a robotic surgery platform that provides positioning assistance during neurosurgical procedures.

Medtronic's robotic platform helps surgeons prepare and carry out precise procedures as part of the company's Surgical Synergy platform.

Dublin-based Medtronic develops device-based medical therapies.